Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Romiplostim for Refractory Transfusion-dependent NSAA
NCT06535685Phase 4Not yet recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- Aug 2024
- Primary completion
- Mar 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of romiplostim in aplastic anemia, sponsored by Peking Union Medical College Hospital. Planned start Aug 2024; status: not yet recruiting.
02
Drugs
romiplostim
03
Conditions
aplastic anemia
Beyond the preview
Go deeper on NCT06535685.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06535685.